AstraZeneca's supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) has been accepted and granted Priority Review in the US for the treatment of patients with muscle-invasive ...
Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies before a patient undergoes surgery, and cancer stage at diagnosis continues to be a leading ...
Nov. 11, 2024 — Researchers have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface.
Breast cancer is the most common cancer in women. It’s important to be aware of the symptoms and to check your breasts regularly. Clare Langford, Medical Negligence Expert at Higgs LLP outlines ...
Breast cancer is the most common cancer in women. It’s important to be aware of the symptoms and to check your breasts regularly. Clare Langford, Medical Negligence Expert at Higgs LLP outlines some ...